Member Info for Soupdragon78

Most basic fact for Mulder to answer, why did you post under another name?
Answer that and you’ll get your answers.

Where’s foremagnus gone Mulder? Don’t you like posting under that name anymore?

It would indeed be nice, although some things cannot be said until they are resolved.

I see why some find it frustrating, but the point I'm making is that was 10 weeks ago.

The following RNS (NXP004 patent on 28th March) made no mention of CEO.

Maybe things changed.

When was that Filter?

Some scenarios don't require a CEO.

correction, not new CEO ast Kissei, new President Yasuo Takehana

ps. Dan was in discussions with a number of Asia companies, not just one.

Jiving, you might be interested in Kissei's new CEO background.

Indeed Mars, if you look back at the Lanstead RNS in December they referred to 'potential licensees' whereas now its 'commercial discussions with licensing partners'

Mars, the key passage on the DG appointment was...

'Nuformix's Executive Chairman, Dr Alastair Riddell, said: " The recent positive pre-clinical studies on NXP002 warrant the progression of further product development and commercial discussions with licensing partners. Dr Gooding brings significant corporate history and experience to the table which will help facilitate these activities.'

especially.... ' ...the progression of further product development and commercial discussions with licensing partners.'

present tense.

Personally I wasn't expecting a weekly update as to what he has been doing.

FX, how do you know DG has done very little so far?

***sighs***

Thanks for the misinformation Mulder.

Firstly Anne Brinkley told us all herself she was involved in Lynparza whilst at AZ. So I don’t need to suggest anything.

Secondly, she resigned long before results on NXP004 were known.

Thirdly, business development was sorted with appointing DG.

Fourth, the company have said they will be doing further work on NXP004 prior to any approach to anyone, not strictly AZ or Merck (remember both are originators)

Fifth, read the patent, it explains how it deals with the side effect profile.

Adios.

Don’t quite understand you there Mars. The FDA have nothing to do with patents.

Filter, they need the patent to be granted first.

Not a sell, someone has been lucky enough to Bed and ISA at this price.

Lol, that filing got changed a long time ago chab.

Filter, if the board are reading this then I’d be very worried.

NFT if the decision was not in the interest of shareholders, why do you think that one shareholder who holds 37m shares and the same in options was part of the decision to close the lab? And if its to their detriment why haven't they sold any?